Texas Children's Buys Enterprise Products Partners LP, Solid Biosciences Inc, ChemoCentryx Inc, Sells Array BioPharma Inc, ACADIA Pharmaceuticals Inc, Sage Therapeutics Inc

• New Purchases: CCXI, IOVA, AMRN, BCRX,
• Added Positions: EPD, SLDB, WVE, UTHR, GHDX, NBIX, BGNE, BMRN,
• Reduced Positions: ARRY, ACAD, INCY, ALXN, ABMD, SGEN, FOLD, ZGNX,
• Sold Out: SAGE, MRUS, AAPL, IMMU, WMT, ADBE, NTAP, CNC, HD, BAX, INTC, ABBV, CSCO, BK, FB, DGX, DFS, PH, GD, KO, EOG,

For the details of Texas Children's's stock buys and sells, go to https://www.gurufocus.com/guru/texas+children%27s/current-portfolio/portfolio

1. Black Stone Minerals LP (BSM) - 2,268,592 shares, 49.82% of the total portfolio.
2. SPDR S&P Oil & Gas Explor & Product (XOP) - 482,603 shares, 18.47% of the total portfolio.
3. Enterprise Products Partners LP (EPD) - 256,470 shares, 9.29% of the total portfolio. Shares added by 91170.46%
4. VanEck Vectors Oil Services (OIH) - 135,589 shares, 2.91% of the total portfolio.
5. Solid Biosciences Inc (SLDB) - 140,733 shares, 1.61% of the total portfolio. Shares added by 750.76%

Texas Children's initiated holding in ChemoCentryx Inc. The purchase prices were between $10.01 and $13.89, with an estimated average price of $11.44. The stock is now traded at around $11.94. The impact to a portfolio due to this purchase was 1.01%. The holding were 58,142 shares as of .

Texas Children's initiated holding in Iovance Biotherapeutics Inc. The purchase prices were between $8.41 and $11.26, with an estimated average price of $9.7. The stock is now traded at around $10.81. The impact to a portfolio due to this purchase was 0.76%. The holding were 64,348 shares as of .

Texas Children's initiated holding in Amarin Corp PLC. The purchase prices were between $12.61 and $22.33, with an estimated average price of $17.95. The stock is now traded at around $16.78. The impact to a portfolio due to this purchase was 0.73%. The holding were 28,197 shares as of .

Texas Children's initiated holding in Biocryst Pharmaceuticals Inc. The purchase prices were between $7.38 and $9.72, with an estimated average price of $8.57. The stock is now traded at around $7.84. The impact to a portfolio due to this purchase was 0.61%. The holding were 60,479 shares as of .

Texas Children's added to a holding in Enterprise Products Partners LP by 91170.46%. The purchase prices were between $24.59 and $29.3, with an estimated average price of $27.88. The stock is now traded at around $28.58. The impact to a portfolio due to this purchase was 9.28%. The holding were 256,470 shares as of .

Texas Children's added to a holding in Solid Biosciences Inc by 750.76%. The purchase prices were between $7.19 and $32.37, with an estimated average price of $16.87. The stock is now traded at around $6.32. The impact to a portfolio due to this purchase was 1.42%. The holding were 140,733 shares as of .

Texas Children's added to a holding in WAVE Life Sciences Ltd by 76.78%. The purchase prices were between $32.69 and $47.91, with an estimated average price of $40.58. The stock is now traded at around $27.72. The impact to a portfolio due to this purchase was 0.64%. The holding were 30,546 shares as of .

Texas Children's added to a holding in United Therapeutics Corp by 65.27%. The purchase prices were between $107.15 and $126.84, with an estimated average price of $116.44. The stock is now traded at around $90.50. The impact to a portfolio due to this purchase was 0.54%. The holding were 9,397 shares as of .

Texas Children's added to a holding in Genomic Health Inc by 48.94%. The purchase prices were between $62.22 and $83.66, with an estimated average price of $74.12. The stock is now traded at around $57.36. The impact to a portfolio due to this purchase was 0.34%. The holding were 11,967 shares as of .

Texas Children's added to a holding in Neurocrine Biosciences Inc by 30.62%. The purchase prices were between $69.31 and $91.53, with an estimated average price of $83.53. The stock is now traded at around $78.81. The impact to a portfolio due to this purchase was 0.22%. The holding were 8,409 shares as of .

Texas Children's sold out a holding in Sage Therapeutics Inc. The sale prices were between $89.33 and $163.65, with an estimated average price of $144.22.

Texas Children's sold out a holding in Merus NV. The sale prices were between $11.09 and $15.83, with an estimated average price of $12.79.

Texas Children's sold out a holding in Apple Inc. The sale prices were between $142.19 and $195.09, with an estimated average price of $169.29.

Texas Children's sold out a holding in Immunomedics Inc. The sale prices were between $13.12 and $19.21, with an estimated average price of $16.02.

Texas Children's sold out a holding in Walmart Inc. The sale prices were between $92.86 and $102.2, with an estimated average price of $97.26.

Texas Children's sold out a holding in Adobe Inc. The sale prices were between $215.7 and $267.69, with an estimated average price of $251.74.

Texas Children's reduced to a holding in Array BioPharma Inc by 63.82%. The sale prices were between $14.25 and $24.45, with an estimated average price of $20.7. The stock is now traded at around $21.56. The impact to a portfolio due to this sale was -0.91%. Texas Children's still held 25,485 shares as of .

Texas Children's reduced to a holding in ACADIA Pharmaceuticals Inc by 58.2%. The sale prices were between $16.17 and $27.38, with an estimated average price of $23.2. The stock is now traded at around $25.60. The impact to a portfolio due to this sale was -0.78%. Texas Children's still held 24,471 shares as of .

Texas Children's reduced to a holding in Incyte Corp by 46.77%. The sale prices were between $63.56 and $88.17, with an estimated average price of $81.08. The stock is now traded at around $76.11. The impact to a portfolio due to this sale was -0.72%. Texas Children's still held 9,125 shares as of .

Texas Children's reduced to a holding in Amicus Therapeutics Inc by 20.77%. The sale prices were between $9.58 and $13.92, with an estimated average price of $12.16. The stock is now traded at around $12.35. The impact to a portfolio due to this sale was -0.16%. Texas Children's still held 45,589 shares as of .